PRE-SALE IS LIVE

Learn More

About Aimedix(AIM)

Scroll to Video

What problem does Aimedix solve? (or: what human need does it satisfy?) and how exactly does it do so?

What is Aimedis?

Aimedis is the next generation e-health platform which will connect the efficiency of AI and the

security of Blockchain to provide cutting edge medical and psychological support. Aimedis is a

platform which will enable patients and doctors to connect with each other 24/7 from

everywhere on the planet while offering never before seen security for patient's personal medical

and psychological data.

The dual blockchain design

The Aimedis security system is based on a dual blockchain architecture, allowing Aimedis users

to keep ownership of their medical data while allowing them to monetize their private data for

medical research purposes or pay for medical services and medication while getting great

discounts by using the AIM token. Medical researchers will be granted only as much or as little

confidential data as desired by the patient in a completely anonymized way, protecting the

patient's sensitive information while allowing them to both profit and contribute to medical

research. The AIMchain private blockchain will make trust visible for the patient and the users

and will finally empower the patient via decentralisation and incentivising.

Connected Patient Communities

Aimedis helps connect patients in to communities using a unique social network system.

Aimedis will provide a dedicated space for patients to share their experiences,

recommendations, feedback, and advice with other patients. By coming together as a

community, patient's benefit from sharing their experiences and in offering support to each other.

This helps in dealing with acceptance and treatment of medical conditions.

The members of this community will have rich media capabilities such as uploading video,

audio, text, or image content, allowing them to connect with their peers. This media and content

is part of a creation-incentivized rewards system where creators of high quality content can be

rewarded by the other community members with votes.

As a community, members will be able to offer financial incentives (via voting) for content

published on the platform. Patient's can use their tokens to pay for services, transact within the

community, or exchange to fiat.

Secondarily, this content will be used as data inputs for our Artificial Intelligence when creating

extensive reports on specific medical conditions and diagnosis. This data is appended

alongside wearables data, scientific data, and more.

How is the idea monetized? How do the token holders profit?

? 20% of Aimedis revenue will directly flow into the AIMsocial fund

? Token can be used to pay services inside the platform and medication in the

AIMedisafe backed online drugstore with discounts

? Token will be used to reward participants in terms of sharing usefully voted content

on AIMsocial - our own medical social network

? The token enables the user to contribute to content creators via upvote + direct

contribution

? Researchers will pay patients for participating in trials via the token

? Token issuance during presale and ICO via Swisscom blockchain portal, which will

issue them directly after contribution

? Legal surveillance by Wenger & Vieli attorneys at law, Zürich & Zug, Switzerland

Other Important Info

Already a proven existing company

Aimedis is an existing company, which operates today in three countries:

Germany, Netherlands and Thailand.

Aimedis works today with several hospital chains as a technology provider

working with medical data, and has helped more than ten thousand patients.

Team

Aimedix's team members.

Michael Kaldasch

Michael Kaldasch

Founder & CEO

Linkedin
Ben J. O. El Idrissi

Ben J. O. El Idrissi

Founder & COO

Linkedin
Sankar GaneshA

Sankar GaneshA

CTO

Linkedin

Roadmap


 
2016 Q3 Start of development Aimedis 1.0
2016 Q3 Start of development Aimedis 1.0
2017 Q3 Launch of Aimedis 1.0 in closed environment
2017 Q4 Getting Certified ISO 9001 & ISO 27001
2017 Q4 SRH hospital group Germany starts using Aimedis for patients
2018 Q1 ICO Whitepaper release
2018 Q2 ICO & Presale iOS & Android Apps
2018 Q3 Start of Asian cooperation program
2018 Q4 Launch of Aimedis 2.0
2019 Q2 Incentivised AIMsocial patient platform
2019 Q3 AIMedisafe secure pharma label
2019 Q4 AIMedisafe backed online drugstore
2020 Q1 Release of Aimedis 3.0 with AI backed diagnosis & therapy program
Read More Read Less

Quick notes

Tokenomics

Token Info

Price: 1 AIM = 0,12 USD Soft Cap: 9.000.000 USD Hard Cap: 36.000.000 USD Buy with: ETH, BTC Platform: Ethereum Location: Switzerland Restricted: USA, China, Singapore

Other Info

MVP/Prototype: Yes Escrow: Yes Category: Health & Nutrition

User ratings

Rate the Profit Potential

What problem does Aimedix solve? (or: what human need does it satisfy?) and how exactly does it do so?

What is Aimedis?

Aimedis is the next generation e-health platform which will connect the efficiency of AI and the

security of Blockchain to provide cutting edge medical and psychological support. Aimedis is a

platform which will enable patients and doctors to connect with each other 24/7 from

everywhere on the planet while offering never before seen security for patient's personal medical

and psychological data.

The dual blockchain design

The Aimedis security system is based on a dual blockchain architecture, allowing Aimedis users

to keep ownership of their medical data while allowing them to monetize their private data for

medical research purposes or pay for medical services and medication while getting great

discounts by using the AIM token. Medical researchers will be granted only as much or as little

confidential data as desired by the patient in a completely anonymized way, protecting the

patient's sensitive information while allowing them to both profit and contribute to medical

research. The AIMchain private blockchain will make trust visible for the patient and the users

and will finally empower the patient via decentralisation and incentivising.

Connected Patient Communities

Aimedis helps connect patients in to communities using a unique social network system.

Aimedis will provide a dedicated space for patients to share their experiences,

recommendations, feedback, and advice with other patients. By coming together as a

community, patient's benefit from sharing their experiences and in offering support to each other.

This helps in dealing with acceptance and treatment of medical conditions.

The members of this community will have rich media capabilities such as uploading video,

audio, text, or image content, allowing them to connect with their peers. This media and content

is part of a creation-incentivized rewards system where creators of high quality content can be

rewarded by the other community members with votes.

As a community, members will be able to offer financial incentives (via voting) for content

published on the platform. Patient's can use their tokens to pay for services, transact within the

community, or exchange to fiat.

Secondarily, this content will be used as data inputs for our Artificial Intelligence when creating

extensive reports on specific medical conditions and diagnosis. This data is appended

alongside wearables data, scientific data, and more.

How is the idea monetized? How do the token holders profit?

? 20% of Aimedis revenue will directly flow into the AIMsocial fund

? Token can be used to pay services inside the platform and medication in the

AIMedisafe backed online drugstore with discounts

? Token will be used to reward participants in terms of sharing usefully voted content

on AIMsocial - our own medical social network

? The token enables the user to contribute to content creators via upvote + direct

contribution

? Researchers will pay patients for participating in trials via the token

? Token issuance during presale and ICO via Swisscom blockchain portal, which will

issue them directly after contribution

? Legal surveillance by Wenger & Vieli attorneys at law, Zürich & Zug, Switzerland

Other Important Info

Already a proven existing company

Aimedis is an existing company, which operates today in three countries:

Germany, Netherlands and Thailand.

Aimedis works today with several hospital chains as a technology provider

working with medical data, and has helped more than ten thousand patients.

Loading ratings...

Questions & Answers

Ask a Question
Loading questions and answers...

ICO Champs investors rating

Overall Rating

 
N/A

Hype

N/A

Profit Potential

N/A

Risk

N/A